1 |
In vitro antibacterial activities of cefiderocol against Gram-negative clinical strains isolated from China in 2020 |
|
|
| Naoki Kohira, Meredith A Hackel, Merime Oota, Miki Takemura, Fupin Hu, Hiromichi Mizuno, Daniel F Sahm, Yoshinori Yamano |
|
| Journal of Global Antimicrobial Resistance. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Tigecycline: Role in the Management of cIAI and cSSTI in the Indian Context |
|
|
| Subramanian Swaminathan, Prithwijit Kundu |
|
| Indian Journal of Clinical Medicine. 2021; : 2633944721 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
Effect of Coptis chinensis on Biofilm Formation and Antibiotic Susceptibility in Mycobacterium abscessus |
|
|
| Cheng-Yin Tseng, Mao-Feng Sun, Tsai-Chung Li, Ching-Ting Lin, Rômulo Dias Novaes |
|
| Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
Analysis of clinical characteristics of tigecycline-induced acute pancreatitis |
|
|
| Weijin Fang, Dan Yi, Linli Sun, Chunjiang Wang |
|
| Journal of Clinical Pharmacy and Therapeutics. 2020; 45(6): 1320 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
Rapid turbidimetric assay to potency evaluation of tigecycline in lyophilized powder |
|
|
| Lucélia Magalhães da Silva,Hérida Regina Nunes Salgado |
|
| Journal of Microbiological Methods. 2015; 110: 49 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Case-Control Study of the Risk Factors for Acquisition of Pseudomonas and Proteus Species during Tigecycline Therapy |
|
|
| Ga Eun Park, Cheol-In Kang, Yu Mi Wi, Jae-Hoon Ko, Woo Joo Lee, Ji Yong Lee, Sun Young Cho, Young Eun Ha, Doo Ryeon Chung, Kyong Ran Peck, Jae-Hoon Song |
|
| Antimicrobial Agents and Chemotherapy. 2015; 59(9): 5830 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
New Therapy Option for Treatment of Methicillin-ResistantStaphylococcus aureusKeratitis: Tigecycline |
|
|
| Sertan Goktas,Muhammet Guzel Kurtoglu,Yasar Sakarya,Ceyhan Ugurluoglu,Muammer Ozcimen,Rabia Sakarya,Ismail Alpfidan,Ismail Senol Ivacik,Erkan Erdogan,Abdulkadir Bukus |
|
| Journal of Ocular Pharmacology and Therapeutics. 2015; 31(2): 122 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Validation of a Stability-Indicating RP-LC Method for the Determination of Tigecycline in Lyophilized Powder |
|
|
| L. M. da Silva,H. R. N. Salgado |
|
| Journal of Chromatographic Science. 2013; 51(2): 192 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections |
|
|
| Y.-T. Lee,S.-M. Tsao,P.-R. Hsueh |
|
| European Journal of Clinical Microbiology & Infectious Diseases. 2013; 32(9): 1211 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Validation of a stability-indicating RP-LC method for the determination of tigecycline in lyophilized powder |
|
|
| Da Silva, L.M., Salgado, H.R.N. |
|
| Journal of Chromatographic Science
. 2013; 51(2): 192-199 |
|
| [Pubmed] [Google Scholar] |
|
11 |
An update for community-acquired bacterial pneumonia pharmacotherapy: Whatæs new and where does it fit? |
|
|
| Debellis, H.F., Jones, M.C., Kincaid, S.E. |
|
| Journal of Pharmacy Practice. 2012; 25(6): 569-575 |
|
| [Pubmed] [Google Scholar] |
|
12 |
In vitro activity of tigecycline against multidrug-resistant Gram-negative blood culture isolates from critically ill patients |
|
|
| S. Gupta, C. Aruna, S. Nagaraj, M. Dias, S. Muralidharan |
|
| Journal of Antimicrobial Chemotherapy. 2012; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
13 |
Confronting multidrug-resistant Acinetobacter baumannii: a review |
|
|
| Ioannis K. Neonakis,Demetrios A. Spandidos,Efthimia Petinaki |
|
| International Journal of Antimicrobial Agents. 2011; 37(2): 102 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
Ceftobiprole: The First Broad-Spectrum Anti–methicillin-resistant Staphylococcus aureus Beta-Lactam |
|
|
| Elias B. Chahine,Adwoa O. Nornoo |
|
| Journal of Experimental & Clinical Medicine. 2011; 3(1): 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Microbial isolation and emergence of antimicrobial resistance associated with tigecycline usage |
|
|
| Li-Yuan Chen, Tun-Chieh Chen, Yen-Hsu Chen, Chun-Yu Lin, Wei-Ru Lin, Po-Liang Lu |
|
| Journal of Microbiology Immunology and Infection. 2011; 44(5): 352 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
16 |
Confronting multidrug-resistant Acinetobacter baumannii: A review |
|
|
| Neonakis, I.K., Spandidos, D.A., Petinaki, E. |
|
| International Journal of Antimicrobial Agents. 2011; 37(2): 102-109 |
|
| [Pubmed] [Google Scholar] |
|
17 |
Ceftobiprole: The First Broad-Spectrum Anti-methicillin-resistant Staphylococcus aureus Beta-Lactam |
|
|
| Chahine, E.B., Nornoo, A.O. |
|
| Journal of Experimental and Clinical Medicine. 2011; 3(1): 9-16 |
|
| [Pubmed] [Google Scholar] |
|
18 |
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease |
|
|
| Cai, Y., Wang, R., Liang, B., Bai, N., Liu, Y. |
|
| Antimicrobial Agents and Chemotherapy. 2011; 55(3): 1162-1172 |
|
| [Pubmed] [Google Scholar] |
|
19 |
Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis |
|
|
| Efthimia Tasina, Anna-Bettina Haidich, Stamatia Kokkali, Malamatenia Arvanitidou |
|
| The Lancet Infectious Diseases. 2011; |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
20 |
Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease |
|
|
| Yun Cai, Rui Wang, Beibei Liang, Nan Bai, Youning Liu |
|
| Antimicrobial Agents and Chemotherapy. 2011; 55(3): 1162 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
21 |
Bacterial contamination of platelets and septic transfusions: Review of the literature and discussion on recent patents about biofilm treatment |
|
|
| Savini, V., Catavitello, C., Astolfi, D., Balbinot, A., Masciarelli, G., Pompilio, A., Quaglietta, A.M., (...), Iacone, A. |
|
| Recent Patents on Anti-Infective Drug Discovery. 2010; 5(2): 168-176 |
|
| [Pubmed] [Google Scholar] |
|
22 |
Glycylcyclines - What should pharmacists know about this new class of antimicrobial? |
|
|
| Van Schoor, J. |
|
| SA Pharmaceutical Journal. 2010; 77(2): 27-30 |
|
| [Pubmed] [Google Scholar] |
|
23 |
Tigecycline: A Review of Properties, Applications, and Analytical Methods : |
|
|
| Lucélia Magalhães da Silva, Hérida Regina Nunes Salgado |
|
| Therapeutic Drug Monitoring. 2010; 32(3): 282-288 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
24 |
A European survey of antibiotic management of methicillin-resistant Staphylococcus aureus infection: current clinical opinion and practice |
|
|
| Dryden, M., Andrasevic, A.T., Bassetti, M., Bouza, E., Chastre, J., Cornaglia, G., Esposito, S., Voss, A. |
|
| Clinical Microbiology and Infection. 2010; 16((SUPPL 1)): 3-30 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
25 |
Prospects for the next anti-Pseudomonas drug |
|
|
| Page, M.G., Heim, J. |
|
| Current Opinion in Pharmacology. 2009; 9(5): 558-565 |
|
| [Pubmed] [Google Scholar] |
|
26 |
Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines |
|
|
| Midtvedt, T. |
|
| Side Effects of Drugs Annual. 2009; 31: 413-425 |
|
| [Pubmed] [Google Scholar] |
|
27 |
Antibiotic therapy of vascular catheter-related bloodstream infections: is vancomycin the optimal choice for Staphylococcus aureus infections? |
|
|
| Stan Deresinski |
|
| International Journal of Antimicrobial Agents. 2009; 34: S43 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|